Description of the Evolution of Functional Dysphonia Managed by Hypnotherapy
NCT ID: NCT05179811
Last Updated: 2024-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
14 participants
OBSERVATIONAL
2022-04-08
2023-10-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improvement in Acoustic Voice Characteristics in Functional Dysphonia After Therapy
NCT02518425
Singing-voice Disorders and Aerodynamic Profiles in Dysodic Singers
NCT04036864
Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia
NCT04612374
Electrophysiological Study of Interindividual Differences in Speech-understanding Among Cochlear Implant Patients
NCT01805167
Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
NCT02061943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Their management, like that of functional neurological disorders in general, is still poorly codified. Different therapeutic strategies are mentioned, especially in the event of speech therapy failure, in particular behavioural and cognitive psychotherapeutic approaches.
The recent explanatory hypotheses of functional neurological disorders are that the processing of sensory and motor information can be modulated, or even inhibited, by cognitive and attentional mechanisms. Different elements (volition, emotions, attention) can exclude certain psychic representations from consciousness.
Hypnosis, by exercising direct control over attentional resources makes it possible to obtain hypoactivation of the medial prefrontal cortex and hyperactivation of the executive and salience networks, making greater use of the buffer of working memory and activate the para-sympathetic system. Thus, one can observe analgesia, amnesia, a loss of the notion of time, plurimodal hallucinations, a detachment from oneself, a distortion of reality and logic.
Hypnosis has been used since the 19th century in the treatment of functional paralysis. To date, there are only presentations and case series evaluating the value of hypnosis in functional disorders of voice and speech. However, from a clinical standpoint, the use of hypnosis seems to show a significant interest in functional speech disorders.
Functional neurological disorders are located at the crossroads of neurological and psychiatric disorders, psychiatric and psychological evaluation of these patients therefore seems necessary in order to measure their impact on the pathological and recovery processes through hypnotherapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
Patients with functional dysphonia using the Voice Handicap Index score.
Hypnosis sessions
* Physical examination
* Psychiatric Assessment
* VHI, SF-36, IPQ-R questionnaires
* Standardized voice recording
* 3 Standardized Hypnotherapy sessions
* CGI-I-Patient Questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypnosis sessions
* Physical examination
* Psychiatric Assessment
* VHI, SF-36, IPQ-R questionnaires
* Standardized voice recording
* 3 Standardized Hypnotherapy sessions
* CGI-I-Patient Questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Supported at the Rothschild Foundation as part of a hypnotherapy protocol
* Mastering the understanding of the French language
* Express consent to participate in the study
Exclusion Criteria
* Decompensation of a psychiatric pathology
* Discovery during study of an organic etiology not initially identified
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cécile HUBSCH
Role: PRINCIPAL_INVESTIGATOR
Hôpital Fondation A. de Rothschild
Stéphane MOUCHABAC
Role: STUDY_DIRECTOR
Hôpital Saint-Antoine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Fondation A. de Rothschild
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHH_2021_22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.